Skip to Content


In some countries, this medicine may only be approved for veterinary use.

In the US, Reserpine (reserpine systemic) is a member of the drug class antiadrenergic agents, peripherally acting and is used to treat High Blood Pressure, Hyperthyroidism and Schizophrenia.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antihypertensive agent

Antisympathotonic agent

Chemical Name

Yohimban-16-carboxylic acid, 11,17-dimetoxy-18-[(3,4,5-trimetoxybenzoyl)oxy]-, metyl ester, (3β,16β,17α,18β,20α)-

Foreign Names

Generic Names

  • Reserpina (OS: DCIT)
  • Reserpine (OS: JAN, BAN)
  • Réserpine (OS: DCF)
  • Mephaserpin (IS)
  • Reserpin (PH: Ph. Eur. 9)
  • Reserpine (PH: BP 2018, JP XVII, Ph. Eur. 9, Ph. Int. 6, USP 41)
  • Réserpine (PH: Ph. Eur. 9)
  • Reserpinum (PH: Ph. Eur. 9, Ph. Int. 6)

Brand Names

  • Adelfan Plus [+ Hydrochlorothiazide, + Dihydralazine]
    Shreechem, Georgia
  • Adelphane [+ Dihydralazine]
    Novartis, India
  • Adelphane-Esidrex [+ Dihydralazine, + Hydrochlorothiazide]
    Novartis, India
  • Adelphan-Esidrex [+ Dihydralazine, Hydrochlorothiazide]
    Sandoz, Georgia
  • A-Lennon-Reserpine
    Pharmacare, South Africa
  • Apoplon
    Daiichi Sankyo, Japan
  • Apoplon 0.1%
    Daiichi Sankyo, Japan
  • Bedin [+ Dihydroergocristine, + Clopamide]
    Pharmaceutical Laboratories, Thailand
  • Behyd RA [+ Benzylhydrochlorothiazide]
    Kyorin Pharmaceutical, Japan; Shinlin Sinseng, Taiwan
  • Brinerdin [+ Clopamide, + Dihydroergocristine]
    Krka, Croatia (Hrvatska); Novartis, Egypt; Novartis AH, South Africa
  • Brinerdina [+Dihydroergocristine, +Clopamide]
    Teofarma, Italy
  • Briserin N [+ Clopamide]
    Novartis Pharma, Germany
  • Dehydri
    Pei Jin, Taiwan
  • Deserpin
    Sinton, Taiwan
  • Doriaton-S [+ Hydrochlorothiazide]
    Health Chemical, Taiwan
  • Fullserpine
    Fu Yuan, Taiwan
  • Higroton-Res [+ Chlortalidone]
    Sandoz, Mexico
  • Hypoten [+ Clopamide, + Dihydroergocristine]
    Pharco, Egypt
  • Igroton Reserpina [+ Chlortalidone]
    Amidpharm, Italy
  • Mano-Ap-Es [+ Hydralazine, + Hydrochlorothiazide]
    Lam Thong, Thailand
  • Normatens [+ Clopamide, + Dihydroergocristine]
    Meda Pharma, Latvia
  • R.H.H
    Johnson, Taiwan; New Chemical, Taiwan
  • Rakelin [veterinary use]
    Ceva Animal Health, Australia; Vetpharm, New Zealand
  • Rauserpine
    CCPC, Taiwan
  • Regroton [+ Chlortalidone]
    Assos, Turkey
  • Relapine
    Chen Ho, Taiwan
  • Reser [+ Hydralazine, + Hydrochlorothiazide]
    T.O. Chemicals, Thailand
  • Reserpine
    Astar, Taiwan; Tai Yu, Taiwan; Taiwan Veterans, Taiwan; Union, Taiwan
  • Resertin
    Gentle, Taiwan
  • Reserzide
    Yuan Chou, Taiwan
  • Serazide
    Winston, Taiwan
  • Seril-K
    Union, Taiwan
  • Serpanin
    Jen Sheng, Taiwan
  • Serpasil
    Biochemie, Indonesia; Novartis, India
  • Sinserpine
    Taiwan Biotech, Taiwan
  • Tensionorme [+ Bendroflumethiazide]
    DB, France
  • Thiadri
    Golden Horse, Taiwan
  • Trianpres
    New Chemical, Taiwan
  • Trisdown
    Royal, Taiwan


BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.